Separate research from China and Thailand have both found that diets high in soy products could be the answer to lower hypertension risk in Asians, in contrast to traditional fruit- or vegetable-rich diets.
Ingredion's new stevia sweetener, the BESTEVIA® Reb M Stevia Leaf Sweetener, has received approval from Food Standards Australia New Zealand (FSANZ) to be used as an 'intense sweetener'.
Thai food manufacturing giant Charoen Pokphand Foods PCL (CP Foods) is targeting 30% of its new product development (NPD) this year to be focused on healthy food products.
Researchers at Monash University Malaysia have embarked on a study to investigate the association of cultural practices and diet with the gut and oral microbiome of indigenous peoples in Malaysia.
Japanese beverage group Asahi is entering Vietnam's infant and child nutrition sector, having recently entered a joint venture with Vietnam Nutrition Food JSC (Nutifood).
A compound isolated from Gynostemma longipes, a plant from a group of climbing vines in the gourd and melon family, has been shown to stimulate muscle growth in a mouse cell model.
Bened Biomedical is moving ahead with its expansion plans, most recently signing a multi-year agreement for its proprietary psychobiotic PS128 with Malaysian pharmaceutical firm Nuvanta.
A combination of probiotics has been found to reduce the severity of oral mucositis caused by radiochemotherapy in nasopharyngeal carcinoma patients, according to a Chinese RCT.
Singapore is rightly proud of its status as South East Asia's leading food and nutrition hub, but the city state is refusing to rest on its laurels, and is now striving to develop a thriving start-up scene and tackle challenges around food safety,...
Meiji and Ezaki Glico are the first two companies approved to produce liquid infant formula in Japan, after Japan’s Ministry of Health, Labour, and Welfare gave the green light.
Kiwi manufacturer Keytone Dairy has expanded its range of dairy and nutritional products with two new formulations, which are expected to support further growth in Asia.
The US Food and Drug Administration took action against 17 companies making illegal Alzheimer’s disease treatment claims. Twelve companies were slapped with warning letters while five received online advisories.
Pharmaceutical firms are making strides in the Australia's medical cannabis space, but supplement and nutraceutical firms will have to wait a long time before they can do the same, says an industry expert.
A trade association director is calling for better multi-sectoral cooperation in India, to minimise the need for authorities to clamp down on nutraceutical and supplement companies in India for labelling violations.
